Open-label, phase 1 pharmacokinetic study to investigate the effect of tizanidine nasal spray compared to that of oral tablets in healthy volunteers for the treatment of Skeletal Muscle Spasm

Trial Profile

Open-label, phase 1 pharmacokinetic study to investigate the effect of tizanidine nasal spray compared to that of oral tablets in healthy volunteers for the treatment of Skeletal Muscle Spasm

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2015

At a glance

  • Drugs Tizanidine (Primary) ; Tizanidine (Primary)
  • Indications Spasm
  • Focus Pharmacokinetics
  • Sponsors MDM SpA
  • Most Recent Events

    • 02 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top